Video: Saiama Waqar, MD, MSCI: Targeting Trop-2: Advances in Antibody-Drug Conjugates

In this month’s LiveLung virtual SCLC meeting, Dr. Saiama Waqar, a thoracic oncologist and Professor of Medicine at Washington University School of Medicine, shares an informative update on antibody-drug conjugates (ADCs) targeting Trop-2 in SCLC. Dr. Waqar discusses what we know, what’s still being studied, and why this approach could offer a potential new path forward in treatment.

If you have been impacted, we invite you to join us at one of our virtual or in-person meetings. Visit https://www.livelung.org/meetingsto learn more and find a meeting near you!

Subscribe to our YouTube channel and click the notification bell so you know when new educational lung cancer videos are available https://www.youtube.com/livelung

This video was recorded during the LiveLung SCLC monthly meeting May 19, 2025.

This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.

LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.